Compare SATS & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SATS | ICLR |
|---|---|---|
| Founded | 2007 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.8B | 15.1B |
| IPO Year | 2007 | 1998 |
| Metric | SATS | ICLR |
|---|---|---|
| Price | $119.92 | $181.56 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 14 |
| Target Price | $127.00 | ★ $201.46 |
| AVG Volume (30 Days) | ★ 5.0M | 889.8K |
| Earning Date | 02-26-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 7.47 |
| Revenue | ★ $15,175,913,000.00 | $8,102,602,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.66 |
| P/E Ratio | ★ N/A | $25.18 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.90 | $125.10 |
| 52 Week High | $119.80 | $221.80 |
| Indicator | SATS | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 75.08 | 48.48 |
| Support Level | $107.59 | $171.99 |
| Resistance Level | $117.15 | $203.91 |
| Average True Range (ATR) | 4.60 | 6.70 |
| MACD | 0.04 | 0.22 |
| Stochastic Oscillator | 94.33 | 34.77 |
Satellite television provides the bulk of EchoStar's revenue. The firm serves about 5 million US satellite customers, about 10% of the traditional television market. It also serves 2 million customers under the Sling brand. EchoStar has also amassed an extensive portfolio of spectrum licenses and is building a nationwide wireless network. It acquired Sprint's prepaid business, serving approximately 7 million customers, primarily under the Boost brand. The firm has agreed to sell a portion of its wireless licenses to AT&T and will rely heavily on the AT&T network to serve customers. EchoStar's legacy businesses provide satellite telecom services and equipment to businesses and consumers, including about 800,000 internet customers.
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.